12.62USD-1.17%Mkt Cap: 204.36M USDP/E: —Last update: 2026-05-26
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, an…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap204.36M USD
Enterprise Value38.99M USD
Revenue (TTM)17.56M USD
Gross Profit6.47M USD
Net Income (TTM)-124.02M USD
Revenue/Share1.679 USD
Last Price12.62 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.68
PEG—
EV/EBITDA-0.26
EV/Revenue2.22
P/S12.71
P/B0.73
EPS (TTM)-14.66
EPS (Forward)-8.35
52W Range
11.602% of range69.97
52W High69.97 USD
52W Low11.60 USD
Profitability
Gross Margin49.34%
Oper. Margin-603.91%
EBITDA Margin0.00%
Profit Margin-946.22%
ROE-50.59%
ROA-44.75%
Growth
Revenue Growth183.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-99.84M USD
CapEx (TTM)3.37M USD
FCF Margin-437.05%
FCF Yield-37.55%
Net Debt-184.18M USD
Net Debt/EBITDA1.23
Balance Sheet
Debt/Equity0.01
Current Ratio6.99
Quick Ratio6.57
Book Value/Sh19.17 USD
Cash/Share11.63 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 1, 2019
Splits
Last Split1:100
Split DateFeb 5, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)46.25 USD
Target Range22.00 USD – 65.00 USD
# Analysts4
Ownership
Shares Out.15.94M
Float15.92M
Insiders0.13%
Institutions31.01%
Short Interest
Short Ratio6.3d
Short % Float18.38%
Short % Out.18.35%
Shares Short2.61M
Short (prev mo.)2.08M
Technical
SMA 5013.75 (-8.2%)
SMA 20019.64 (-35.7%)
Beta1.69
S&P 52W Chg28.31%
Avg Vol (30d)425.35K
Avg Vol (10d)404.22K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—